Accurate interpretation and appropriate expression of emotions are key aspects of social-cognition. Several mental disorders are characterised by transdiagnostic difficulties in these areas and, recently, there has been increasing interest in exploring the effects of oxytocin on social-emotional functioning.
Introduction
Accurate interpretation of other's emotions, appropriate expression of one's own emotions, and reciprocity within interactions are key aspects of social cognition. In social interaction, emotion expression is believed to be dependent on accurate interpretation of social signals (Hess and Fischer, 2013; Künecke et al., 2014) . According to the embodied simulation theory, emotion expression and mimicry, in turn, play an important role in facilitating the interpretation of others' expressions, empathy, and prosocial behaviour in recipients (Gallese, 2005) . Indeed, behavioural studies have documented that automatic mimicry of emotions facilitates recognition, whereas blocking mimicry impairs recognition accuracy and sensitivity (Argaud et al., 2016; Duffy and Chartrand, 2015; Künecke et al., 2014; Rychlowska et al., 2014; Schneider et al., 2013) . Anomalies in emotion expression also have social and affective consequences, with incongruent emotion expression increasing the desire for greater social distance and negative social evaluation by the recipient (Brown et al., 2015; Szczurek et al., 2012) . Similarly, expressive suppression has been found to increase the suppressors' blood pressure, subjective anxiety, and social isolation (Butler et al., 2003; Gross, 2002) .
Anomalies in social-emotional functioning are important transdiagnostic features in several psychiatric disorders (Bora and Berk, 2016; Bora and Köse, 2016; Chung et al., 2014; Davies et al., 2016; Henry et al., 2014; Kring and Moran, 2008) . Meta-analyses have found that people with eating disorders (EDs), depression, schizophrenia, and autism spectrum disorders (ASD) have similar difficulties in accurate interpretation of emotions, including recognition of basic emotions in faces and tone of voice with small effect sizes and in emotional theory of mind with medium to large effect sizes (Bora and Berk, 2016; Bora and Köse, 2016; Caglar-Nazali et al., 2014; Chung et al., 2014; Uljarevic and Hamilton, 2013) . Recent systematic reviews have also found that people with schizophrenia, EDs, depression, ASD, and borderline personality disorder (PBD) display less positive facial affect in response to positive emotional stimuli (Davies et al., 2016; Kring and Moran, 2008) . Furthermore, a meta-analysis of 537 task-based fMRI studies in depression, bipolar disorder, schizophrenia, and obsessive-compulsive disorder failed to find significant differences between the disorders in whole brain neural response to social and cognitive tasks (Sprooten et al., 2016) . Together these findings suggest that anomalies in social-emotional processing in psychiatric disorders may have shared underlying mechanisms. Given social and affective consequences of these difficulties, better understanding of the underlying processes is of interest. One such possible mechanism is the oxytocin system.
Preclinical studies have found that the neuropeptide, oxytocin, may regulate social-emotional functioning (Dölen et al., 2013; Hicks et al., 2012; Lim and Young, 2006; Lukas et al., 2011; Onaka et al., 2012) . Endogenous oxytocin has been found to play an important role in the central and medial amygdala, facilitating formation of social bonds, maternal behaviour, and social recognition in rodents (Lim and Young, 2006; Onaka et al., 2012) . Additionally, a recent study found that formation of social reward was dependent on coordinated activity between oxytocin and serotonin in the mouse nucleus accumbens (Dölen et al., 2013) . In rodents, the administration of oxytocin receptor agonist and exogenous synthetic oxytocin has also been found to increase social place preference and reduce social defeat induced avoidance (Hicks et al., 2012; Lukas et al., 2011) . Conversely, the administration of oxytocin receptor antagonist, has been found to increase corticosteroid levels and induce social avoidance in monkeys during times of stress (Cavanaugh et al., 2016) .
Recently there has been increasing interest in translating these findings into humans and the effects of intranasal oxytocin on socialemotional function has been widely studied (Bakermans-Kranenburg and van Ijzendoorn, 2013; Bartz et al., 2011; Guastella and MacLeod, 2012; Shahrestani et al., 2013; van Ijzendoorn and BakermansKranenburg, 2012) . A few previous meta-analytic reviews have found that intranasal oxytocin improves recognition of anger and happiness, and increases in-group trust among healthy individuals with small effect sizes (Shahrestani et al., 2013; van Ijzendoorn and BakermansKranenburg, 2012) . However, to our knowledge no meta-analyses to date have investigated the effects of a single dose of oxytocin on recognition of all six basic emotions, other aspects of emotion interpretation, including theory of mind or sensitivity to recognise basic emotions, or on emotion expression among healthy individuals.
To date, two meta-analytic reviews have investigated the effects of intranasal oxytocin on different aspects of social-emotional functioning in a variety of clinical groups (Bakermans- Kranenburg and van Ijzendoorn, 2013; Ooi et al., 2017) . One reported small, but generally positive effect of intranasal oxytocin on social-emotional functioning and psychopathology among people with ASD, anxiety disorders, depression, schizophrenia, and BPD (Bakermans- Kranenburg and van Ijzendoorn, 2013) . The other meta-analysis found no significant effects of intranasal oxytocin on social-emotional processing in ASD (Ooi et al., 2017) . However, these reviews were quite heterogeneous pooling studies assessing psychopathology and social-emotional processing, or single dose and repeated dose studies into one meta-analysis (Bakermans- Kranenburg and van Ijzendoorn, 2013; Ooi et al., 2017) . To our knowledge no previous meta-analyses have investigated the effects of a single dose of intranasal oxytocin separately on different aspects of interpretation and expression of emotions among both healthy and clinical populations. In order to consider the possibility of translating animal studies more widely into treatment for psychiatric disorders it is important to consider various key outcomes and whether there is evidence that they might be modified by oxytocin.
The aim of the current review was to pool studies investigating the effects of a single dose of intranasal oxytocin on various aspects of social-emotional functioning among healthy and clinical populations. Specifically, we aimed to examine the effects of intranasal oxytocin on theory of mind, recognition of basic emotions, sensitivity to recognise basic emotions, and on emotion expression among healthy and clinical populations. We tested the hypothesis that oxytocin would improve all aspects of social-emotional functioning.
Methodology

Literature searches
Electronic databases, including OVID (journals@OVID, PsycINFO, PsycARTICLES, Embase, AGRIS, MEDLINE), PubMed, and Web of Knowledge core collection, were searched for studies published during available years up to February 2017 in accordance with the PRISMA guidelines (Moher et al., 2009) . Two separate literature searches were conducted in order to uncover studies investigating the effects of a single dose of intranasal oxytocin on interpretation and expression of emotions in a social context. The first literature search was conducted with the following search terms: oxytocin AND emotion AND (interpretation OR recognition OR identification OR labelling OR "theory of mind" OR mentalising OR perception OR empath*). The second search was conducted with the following search terms: oxytocin AND emotion AND (expression OR mimicry OR mirroring OR communication OR responsiveness OR expressivity). Additionally, to ensure no studies were missed by the initial search, the bibliographies of included studies were searched for additional studies.
Eligibility criteria
Studies were included if they met the following inclusion criteria: 1) investigated the effects of a single dose of intranasal exogenous oxytocin on interpretation or expression of emotions in a social context among either healthy adult participants or adult clinical populations (18 years old or older); 2) compared the effects of intranasal oxytocin with intranasal placebo spray; 3) investigated short term outcomes; and 4) randomly allocated participants to oxytocin and placebo groups or, in the case of crossover, within subjects studies, randomised the treatment order. Any studies, which used tasks that did not include a social component, such as the bumper car theory of mind task where social context is inferred from the movement of triangles on a computer screen, were excluded. Trials, in which participants either received repeated doses of oxytocin or in which long term outcomes of a single dose of oxytocin were assessed, were excluded. Studies that included only children or adolescents were excluded, because the majority of them were longer trials and the effects of oxytocin on social-emotional processing can be different in adults and children. Full-text articles published in peer reviewed journals and where possible, published conference abstracts were included.
In total, five studies were excluded after further screening because they incorporated tasks that were very different compared to the other included studies despite being otherwise relevant. These studies included a theory of mind task involving infant stimuli, continuously assessing the mood of a target on a video clip on a 9-point Likert scale, manipulating the context in which emotional stimuli was presented, recognising emotions from a point-light-display, and interpreting basic emotions from tone of voice in different languages (Bartz et al., 2010; Bernaerts et al., 2016; Perry et al., 2013; Voorthuis et al., 2014) .
Study selection
The literature searches were conducted by one author (J.L.). The studies yielded from the literature search were then screened based on their titles and abstracts. Full text articles were then assessed for eligibility followed by final screening and assessment by two authors (J.L. and K.W.N.). Where appropriate conference abstracts of studies not yet published were also screened and assessed for eligibility. If deemed eligible the authors were contacted in order to gain access to the data. Only studies that both authors agreed on were included in the final systematic review and meta-analyses. Any cases where eligibility remained in question were brought to the whole team for further discussion and assessment. The study selection processes of the two searches are presented in Figs. 1 and 2.
Data collection and synthesis
Seventeen studies reported their results in figures or otherwise did not include the relevant data in the paper or supplementary materials. The corresponding authors of these papers were contacted by K.W.N. in order to gain access to the relevant data. The authors of the following papers provided the required data via personal correspondence: Aoki et al. (2014) , Averbeck et al. (2012) , Cardoso et al. (2014a) , Chen et al. (2015) , Fischer-Shofty et al. (2010) , Kirkpatrick et al. (2014) , Koch et al. (2016) , Korb et al. (2016) , and Luminet et al. (2011) .
In order to conduct meta-analyses means, standard deviations, and samples sizes for both oxytocin and placebo groups or sessions were extracted from the studies or acquired through personal correspondence. Where standard error of the mean was reported, standard deviation was estimated with the following formula SD SE N = * . Altogether ten meta-analyses were conducted to investigate the effects of a single dose of intranasal oxytocin on interpretation and expression of emotions. The first meta-analysis investigated the effects of intranasal oxytocin on emotional theory of mind among healthy and clinical populations. The second meta-analysis investigated the effects of a single dose of intranasal oxytocin on interpretation of basic emotions among healthy and clinical populations. Five out of fifteen studies included in the overall basic emotion recognition meta-analysis included all six basic emotions. Thus, to provide further information about the effects of intranasal oxytocin on each of the six basic emotions, separate meta-analyses were conducted on recognition of anger, fear, disgust, sadness, surprise, and happiness among healthy and clinical populations. The last two meta-analyses investigated the effects of intranasal oxytocin on emotion recognition sensitivity and expression of congruent emotions in response to emotionally provoking stimuli. The clinical category included people with ASD, schizophrenia, depression, anorexia nervosa (AN), bulimia nervosa (BN), BPD, posttraumatic stress disorder, behavioural variant of frontotemporal dementia (FTD), alcohol dependence disorder, and opioid dependence disorder.
Additional information regarding age, the oxytocin dose (in international units [IU] ), the specific diagnosis of clinical participants, the proportion of female participants in the sample, and type of task used were also recorded. We also included information regarding the presence of ceiling effects in accuracy scores. Since there are currently no guidelines to indicate what should be used as a cut-off for ceiling effects, we chose an arbitrary cut-off of 85%. Studies, in which the accuracy scores were greater than or equal to 85%, were coded as having evidence of ceiling effects. The additional information was used to conduct meta-regressions to identify variables that might explain any potential between-study heterogeneity.
Emotion interpretation tasks
The emotion interpretation tasks included are summarised in 2003), and the Sally Anne task (Baron-Cohen et al., 1985) . In the RMET participants are presented with 36 photographs of eyes and asked to select one of four words that best describes the complex emotion displayed. The MSCEIT has six subscales, three of which were of interest for the current review and assessed perception of emotions in others and understanding of how emotions change and blend together. The TASIT has three subscales, two of which were of interest for the current review and assessed emotional evaluation and social-emotional inference based on verbal and visual stimuli. Finally, the Sally Anne task assesses emotional and cognitive theory of mind with black and white comic strips. The current reviewed only included data on emotional theory of mind. The studies that investigated the effects of a single dose of intranasal oxytocin on interpretation of basic emotions mostly used standard emotion recognition paradigms in which participants were presented with a photograph of a face depicting a basic emotion and asked to identify the emotion. A subset of studies used dynamic emotion recognition tasks, in which participants were presented with a neutral face that gradually morphed into the full emotion, or masked emotion recognition tasks, in which the photograph of a face depicting a basic emotion was either preceded or followed by a neutral face. The outcome was recognition accuracy. All studies used standardised stimuli to assess emotion recognition accuracy.
All studies examining interpretation sensitivity used similar dynamic emotion recognition tasks as described above. In these tasks participants were initially presented with a neutral face that gradually morphed into full emotion. The outcome was estimated as the intensity percentage at which participants accurately recognised the emotion. Lower the intensity percentage, the more sensitive the participants were to detect the emotion. All studies used standardised stimuli to assess emotion recognition sensitivity.
Emotion expression tasks
The emotion expression tasks included are summarised in Table 1. All included studies used different paradigms to elicit positive and negative emotions. One of the studies presented participants with emotionally provoking positive and negative images from the International Affective Picture System (IAPS). Two of the studies presented participants with short film clips. In one study the film clips depicted either a happy face that gradually morphed into an angry expression or an angry face that gradually morphed into a happy expression. The other study presented participants with excerpts from movies that were designed to elicit happy and sad emotions. Lastly, one study assessed expressions of flight and affiliation during a clinical interview. Participants facial expression were recorded either by manually assessing facial expression using the Facial Expression Coding System (FACES, (Kring and Sloan, 1991) ), using facial electromyography (EMG), or using automated facial emotion detection software, Noldus FaceReader (Noldus Information Technology b.v., www.noldus.com).
Statistical analysis
All statistical analysis was performed using R (R Core Team, 2015) . For studies using between subjects design Hedges' g was calculated to estimate unbiased effect size with 95% confidence intervals. For studies using within subjects design standardised mean change (SMC) with change score standardisation was calculated to estimate effect size with 95% confidence intervals. The SMC controls for the correlation in task performance between the two assessments (oxytocin session and placebo session). Where correlation between the two assessments was not reported, the correlation coefficient was estimated using the following formula r = (≥0.80) (Hedges, 1981) . In nine of the ten meta-analyses higher scores indicated either greater accuracy or greater facial expressivity. Thus, in these meta-analyses positive effect size indicated improved emotion interpretation accuracy or increased emotion expression following oxytocin administration, whereas negative effect size indicated poorer emotion interpretation or reduced emotion expression following oxytocin administration. In the meta-analysis investigating emotion recognition sensitivity lower scores indicated greater sensitivity to recognise the facial expressions. Thus, in this meta-analysis negative effect sizes indicated increased sensitivity to recognise emotions following oxytocin administration and positive effect sizes indicated reduced sensitivity to recognise emotions following oxytocin administration. Significance threshold was set at p < 0.05 unless otherwise stated. The user contributed Metafor package was used to conduct the meta-analyses, meta-regressions, and publication bias estimation (Viechtbauer, 2010) . The meta-analyses were conducted with a multivariate random effects model with an autoregressive structure using the rma.mv function in Metafor to account for correlations arising from multiple outcomes from the same sample. Between-study heterogeneity was assessed by calculating Cochran's Q index and I 2 index. Where between-study heterogeneity was found meta-regressions were conducted and the moderator effects of the following variables was assessed: age, the dose administered (in IU), the specific diagnosis of clinical participants, the type of task used, the proportion of female participants in the sample, and whether there were ceiling effects present (accuracy ≥ 85%). All binary and categorical moderators were dummy coded and entered into the meta-regression using the factor function. The impact of each moderator was assessed in separate models. Influential studies and extreme outliers were identified by inspecting Cook's distance plots and the standardised residuals of each individual study. Where the z-score of the standardised residuals exceeded 1.96, the study was deemed to be an outlier (Viechtbauer and Cheung, 2010) . To test the impact of any outliers on the pooled effect size estimate, we conducted the meta-analysis with the outlier present followed by a meta-regression to examine whether the outlier significantly explained the between study heterogeneity. If the outlier significantly explained the heterogeneity, the outlier was excluded and only results from the meta-analysis without the outlier were reported in full. This procedure led to exclusion of one study (Xu et al., 2015) from two separate meta-analyses.
Publication bias was investigated with Begg's rank correlation test for funnel plot asymmetry (Begg and Mazumdar, 1994) and where significant effects were present Rosenthal's file drawer analysis was also conducted (Rosenthal, 1979) . The robustness of the significant findings was assessed by calculating the Rosenthal's criterion (5n + 10, n = the number of studies in the meta-analysis) and comparing that figure to the fail-safe N from the file drawer analysis. If the fail-safe N exceeded the criterion the findings were considered robust, if it did not this was taken as an indicator of publication bias.
Finally, the statistical power of each study included in the review was assessed by comparing the sample sizes in these studies against that recommended by a power calculation conducted with G*Power (Faul et al., 2007) . According to the power calculation studies using between subjects design should have at least 64 participants in each group while studies using within subjects design should have at least 34 participants altogether, to have adequate statistical power (≥80%) to reliably detect a moderate difference (ES ≥ 0.5) between the two groups or conditions.
Results
Study characteristics
The characteristics of the 33 included studies are summarised in Table 1 . The effect size estimate (ES) represents standardised mean difference (Hedges' g) or standardised mean change (SMC) in interpretation and expression of emotions following oxytocin and placebo. The last column in Table 1 indicates whether the study met the sample size requirement for adequate statistical power (≥80%) to reliably detect at least a medium sized effect between the oxytocin and placebo groups or conditions. None of the studies that used between subjects design met the requirement for adequate power, but five of the studies that used within subjects design did meet this requirement.
Effects of oxytocin on interpretation of emotions
Theory of mind
Fourteen studies were included in the meta-analysis investigating the effects of a single dose of intranasal oxytocin on emotional theory of mind (Fig. 3) . Six of the studies included clinical populations, namely individuals with ASD, AN, depression, schizophrenia, and FTD, and two studies included individuals with substance dependence disorder, including opioid and alcohol dependence. Overall, there was no significant effect of oxytocin on theory of mind (ES = 0.09, Z = 1.14, p = 0. There was evidence of significant between-study heterogeneity (Q = 65.85, p < 0.0001, I 2 = 58.42%), which was further explored with meta-regressions. The findings from the meta-regressions were corrected for multiple comparisons with Bonferroni correction (0.05/6) and p < 0.008 was considered significant. The meta-regressions revealed a significant moderator effect of age (Qm = 7.33, p = 0.007; Supplementary Fig. 1 ), still leaving some residual heterogeneity (Qr = 34.26, p = 0.012). This finding suggests that younger participants showed greater oxytocin-induced improvement in emotional theory of mind. The dose administered (Qm = 1.04, p = 0.309; Supplementary Fig. 2 ), the type of task used (Qm = 2.78, p = 0.427), the diagnostic group (Qm = 0.01, p = 0.918), and the proportion of female participants in the sample (Qm = 1.36, p = 0.243; Supplementary Fig. 3 ) did not significantly explain the between-study heterogeneity.
Begg's rank correlation test of funnel plot asymmetry approached significance suggesting there may have been some publication bias (T = 0.29, p = 0.057; Supplementary Fig. 4 ).
Recognition of basic emotions
Seventeen studies investigated the effects of intranasal oxytocin on total basic emotion recognition accuracy. Based on standardised residuals and Cook's distance, one study by Xu et al. (2015) was identified as an extreme outlier (standardised res. = 2.68, Z = 4.56, SE = 0.59; Supplementary Table 1; Supplementary Fig. 5 ). The impact of the outlier on the meta-analysis was investigated by conducting a meta-analysis with the outlier present, which yielded a significant oxytocin-induced improvement in recognition of basic emotions with a small effect size along with significant between-study heterogeneity (ES = 0.28, Z = 2.56, p = 0.011, 95% CI [0.07, 0.50], k = 33, N of levels = 23, Q = 99.98, p < 0.0001, I 2 = 81.12%). We then investigated whether the outlier was significantly different from the other studies by conducting a meta-regression, which revealed that the outlier significantly explained the between-study heterogeneity (Qm = 46.98, p < 0.0001) leaving no significant residual heterogeneity (Qr = 43.51, p = 0.067). Therefore, the outlier was removed from further analysis. Full meta-analysis was conducted with the remaining sixteen studies (Fig. 4) . The between-study heterogeneity approached significance (Q = 42.08, p = 0.089, I 2 = 30.27%), and was therefore, explored further with meta-regressions. The findings from the meta-regressions were corrected for multiple comparisons with Bonferroni correction (0.05/7) and p < 0.007 was considered significant. The proportion of female participants in the sample (Qm = 1.34, p = 0.247; Supplementary Fig. 6 ), the diagnostic group (Qm = 3.47, p = 0.482), age (Qm = 0.67, p = 0.414; Supplementary Fig. 7 ), the dose administered (Qm = 0.49, p = 0.486; Supplementary Fig. 8 ), the type of task used (Qm = 1.32, p = 0.858), and the presence of ceiling effects (Qm = 1.48, p = 0.224) did not significantly explain the betweenstudy heterogeneity. Begg's rank correlation test of funnel plot asymmetry did not reveal significant publication bias (T = −0.08, p = 0.506; Supplementary  Fig. 9 ). Rosenthal's the file drawer analysis indicated a fail-safe N of 182, suggesting that 182 studies finding no significant effects of oxytocin on recognition of basic emotions would be required to reduce the observed effects to null. This exceeds Rosenthal's criterion for this meta-analysis (5n+10=90) suggesting that the effect was quite robust.
Since the total scores in most of the included studies did not consist of all six basic emotions further meta-analyses were conducted to examine if he above effect was driven by a subset of basic emotions. Thus, we conducted six additional meta-analyses to investigate the effects of a single dose of intranasal oxytocin on the recognition of anger, fear, disgust, sadness, surprise, and happiness. Where possible the studies were divided into healthy and clinical subgroups, which were both inspected separately.
Recognition of anger
Ten studies investigated the effects of intranasal oxytocin on recognition of anger (Fig. 5) . Two of these studies included people with schizophrenia and BPD.
Overall There was no evidence of significant between-study heterogeneity (Q = 21.16, p = 0.219, I 2 = 3.45e-09%) There was also no evidence of significant publication bias on the Begg's rank correlation test of funnel plot asymmetry (T = 0.03, p = 0.881; Supplementary Fig. 10 ).
Recognition of fear
Nine studies investigated the effects of intranasal oxytocin on recognition of fear (Fig. 6) . Two of the studies included people with schizophrenia and BPD.
Overall, oxytocin administration significantly improved recognition of fear with a small effect size (ES = 0. The between-study heterogeneity approached significance (Q = 19.95, p = 0.096, I 2 = 20.92%) and was therefore explored further with meta-regressions. The findings from the meta-regressions were corrected for multiple comparisons with Bonferroni correction (0.05/7) and p < 0.007 was considered significant. The dose administered (Qm = 4.19, p = 0.041; Supplementary Fig. 11 ), the proportion of female participants in the sample (Qm = 0.23, p = 0.632; Supplementary Fig. 12 ), the presence of ceiling effects (Qm = 0.05, p = 0.831), age (Qm = 2.56, p = 0.109; Supplementary Fig. 13 ), the type of task used (Qm = 0.78, p = 0.676), and the diagnostic group (Qm = 0.90, p = 0.638) did not significantly explain the betweenstudy heterogeneity.
There was no evidence of significant publication bias on the Begg's rank correlation test of funnel plot asymmetry (T = −0.08, p = 0.747; Supplementary Fig. 14) . Rosenthal's file drawer analysis revealed a failsafe N of 59, suggesting that 59 additional studies reporting no effect of oxytocin would be needed to reduce the observed effect to null. This exceeds Rosenthal's criterion for this meta-analysis (5n+10 = 55), suggesting the effect was quite robust.
Recognition of disgust
Four studies investigated the effects of oxytocin on the recognition of disgust (Fig. 7) . Because only one of these studies included clinical populations, namely people with schizophrenia, it was not possible to investigate the effects of oxytocin separately within the healthy and clinical populations. Thus, the data was analysed across groups.
The meta-analysis showed a negligible oxytocin-induced improvement in the recognition of disgust, which approached significance (ES = 0.18, Z = 1.73, p = 0.083, 95% CI [-0.02, 0.39], k = 5, N of levels = 4).
There was no evidence of significant between-study heterogeneity (Q = 2.07, p = 0.722, I 2 = 2.73e-08%).
There was no evidence of significant publication bias on the Begg's rank correlation test of funnel plot asymmetry (T = 0.20, p = 0.817; Supplementary Fig. 15 ).
Recognition of sadness
Seven studies investigated the effects of oxytocin on the recognition of sadness (Fig. 8) . As above, since only one study included a clinical group, people with schizophrenia, the meta-analysis was conducted across groups. The meta-analysis revealed no significant effects of oxytocin on the recognition of sadness (ES = 0.04, Z = 0.53, p = 0.594, 95% CI [-0.10, 0.17]). There was also no significant between-study heterogeneity (Q = 7.59, p = 0.474, I 2 = 16.67%).
There was no evidence of significant publication bias on the Begg's rank correlation test of funnel plot asymmetry (T = 0.33, p = 0.260; Supplementary Fig. 16 ).
Recognition of surprise
Four studies investigated the effects of oxytocin on the recognition of surprise (Fig. 9 ). Since only one study included a clinical group, people with schizophrenia, the meta-analysis was conducted across groups.
The meta-analysis revealed no significant effect of oxytocin on the recognition of surprise (ES = −0.02, Z = −0.16, p = 0.874, 95% CI [-0.22, 0.19] , k = 5, N of levels = 4). There was also no evidence of significant between-study heterogeneity (Q = 3.72, p = 0.445, I 2 = 1.90e-08%)
There was no evidence of significant publication bias on Begg's rank correlation test of funnel plot asymmetry (T = 0.20, p = 0.817; Supplementary Fig. 17 ).
Recognition of happiness
Twelve studies investigated the effects on intranasal oxytocin on the recognition of happiness. Following inspection of the standardised residuals and Cook's distance one study by Xu et al. (2015) was identified as an extreme outlier (standardised res. = 2.83, Z = 3.27, SE = 0.87; Supplementary Table 2, Supplementary Fig. 18 ). The metaanalysis with the outlier present yielded no significant effect of oxytocin on the recognition of happiness, but there was significant betweenstudy heterogeneity (ES = 0.31, Z = 1.26, p = 0.207, 95% CI [-0.17, 0 .79], k = 20, N of levels = 12, Q = 93.93, p < 0.0001, I 2 = 93.34%). A meta-regression revealed that the outlier significantly explained the between-study heterogeneity (Qm = 51.44, p < 0.0001) leaving no significant residual heterogeneity (Qr = 28.36, p = 0.057). Therefore, the outlier was removed from further analysis.
The eleven remaining studies were included in the final metaanalysis (Fig. 10) The between-study heterogeneity approached significance (Q = 27.87, p = 0.064, I 2 = 33.62%) and was explored further with meta-regressions. The findings from the meta-regressions were corrected for multiple comparisons with Bonferroni correction (0.05/7) and p < 0.007 was considered significant. The type of task used (Qm = 11.36, p = 0.010), the proportion of female participants in the sample (Qm = 0.84, p = 0.360; Supplementary Fig. 19 ), age (Qm = 0.07, p = 0.789; Supplementary Fig. 20 ), the dose administered (Qm = 2.67, p = 0.103; Supplementary Fig. 21 ), the diagnostic group (Qm = 2.84, p = 0.242), and the presence of ceiling effects (Qm = 3.29, p = 0.070), did not significantly explain the betweenstudy heterogeneity.
There was no evidence of significant publication bias on the Begg's rank correlation test of funnel plot asymmetry (T = −0.13, p = 0.447; Supplementary Fig. 22 ).
Emotion recognition sensitivity
Three studies investigated the effects of intranasal oxytocin on emotion recognition sensitivity (Fig. 11) . Because only one of these studies included clinical groups, people with AN and BN, the metaanalysis was conducted across groups.
Overall, intranasal oxytocin did not significantly influence emotion recognition sensitivity (ES = −0.14, Z = −1.45, p = 0.146, 95% CI The between-study heterogeneity approached significance (Q = 29.31, p = 0.061, I 2 = 67.31%) and was explored further with meta-regressions. The findings from the meta-regressions were corrected for multiple comparisons with Bonferroni correction (0.05/5) and p < 0.01 was considered significant. The proportion of female participants in the sample (Qm = 0.03, p = 0.864; Supplementary  Fig. 23 ), age (Qm = 1.27, p = 0.261; Supplementary Fig. 24 ), the dose administered (Qm = 0.03, p = 0.864; Supplementary Fig. 25 ), and the diagnostic group (Qm = 2.03, p = 0.567) did not significantly explain the heterogeneity. Begg's rank correlation test of funnel plot asymmetry revealed evidence of significant publication bias (T = −0.74, p < 0.0001; Supplementary Fig. 26 ) indicating that small studies finding larger effects were more likely to be published.
Effects of oxytocin on emotion expression
Four studies investigated the effects of a single dose of intranasal oxytocin on expression of congruent emotions in response to emotionally provoking stimuli (Fig. 12) . Three studies included individuals with clinical conditions, including BPD, Schizophrenia, and AN.
Overall, there was no significant effect of oxytocin on emotion expression (ES = 0.08, Z = 0.87, p = 0.385, 95% CI [-0.10, 0.26] , k = 14, N of levels = 7). When the data was further inspected, the meta-analysis showed that oxytocin significantly increased the expression of positive emotions among the healthy individuals with a small There was significant between-study heterogeneity (Q = 23.14, p = 0.040, I 2 = 35.95%), which was explored further with metaregressions. The proportion of female participants in the sample, age, and the dose administered individually significantly explained the heterogeneity . These variables were, thus, entered into a full model which significantly explained the betweenstudy heterogeneity (Qm = 8.80, p = 0.032) leaving no significant residual heterogeneity (Qr = 14.33, p = 0.158) . This finding suggests that older male participants who received 24IU of intranasal oxytocin showed greater oxytocin induced increase in facial expressivity. However, this meta-analysis consisted of only four studies and, thus, this finding should be interpreted with caution. The diagnostic group (Qm = 6.14, p = 0.105)did not significantly explain the heterogeneity. There was no evidence of significant publication bias on the Begg's rank correlation test of funnel plot asymmetry (T = −0.03, p = 0.915; Supplementary Fig. 30 ). However, Rosenthal's file drawer analysis revealed a fail-safe N of 1, indicating that only 1 study finding no significant effects of oxytocin on emotion expression would be needed to reduce the observed significant effect to null. This does not exceed the Rosenthal's criterion for this meta-analysis (5k+10 = 30) indicating that this finding is not robust and there is likely to be substantial publication bias present.
Discussion
The aim of the current meta-analytic review was to investigate the effects of a single dose of intranasal oxytocin on interpretation and expression of emotions among healthy and clinical populations. Most the studies recruited only healthy individuals, but thirteen studies also included people with clinical disorders and two studies included people with substance dependence disorder. The meta-analyses revealed that a single dose of intranasal oxytocin significantly improved the recognition of basic emotions, particularly fear, but only among healthy individuals with small to negligible effect sizes. Oxytocin also increased the expression of positive emotions with a small effect size among the healthy individuals. Intranasal oxytocin did not significantly influence theory of mind among the healthy individuals. Although, the oxytocininduced improvement in basic emotion recognition approached significance, overall there were no significant effects on intranasal oxytocin on the interpretation or expression of emotions among the mixed clinical population.
The oxytocin-induced increase in the expression of positive emotions in healthy individuals is in line with findings from previous systematic reviews and suggests that oxytocin plays an important role in facilitating prosocial behaviour in humans (Bakermans-Kranenburg and van Ijzendoorn, 2013; Churchland and Winkielman, 2012; Guastella and MacLeod, 2012 ). This finding is also supported by previous work that has documented increased trust and cooperation particularly towards the members of a safe "in-group" following oxytocin administration (van Ijzendoorn and Bakermans-Kranenburg, 2012) . Together these findings suggest that oxytocin may facilitate prosocial behaviour among healthy individuals. However, it is of importance to note that the oxytocin-induced increase in the expression of positive emotions was not robust, and it is likely that there was substantial publication bias present.
The present findings also showed that intranasal oxytocin improved recognition of basic emotions, which appeared to be largely driven by oxytocin-induced significant improvement in fear recognition and nearly significant improvement in disgust recognition. These results may seem surprising in this light of the findings above. However, these results are in line with a previous meta-analysis, which also found that intranasal oxytocin improved early recognition of angry faces and late recognition of fearful faces among healthy individuals (Shahrestani et al., 2013) . Additionally, intranasal oxytocin has also been found to increase attention and approach towards negative social-emotional stimuli, such as angry and fearful facial expressions (Clark-Elford et al., 2015; Simon et al., 2012; Tollenaar et al., 2013) .
Recent systematic reviews have attempted to explain the recent emergence of similar seemingly contradictory findings by suggesting that the effects of intranasal oxytocin may be modulated by social boundaries (Olff et al., 2013; Zik and Roberts, 2015) . This hypothesis suggests that oxytocin may be of evolutionary importance in social interactions, increasing pro-social behaviour towards "safe" stimuli and defensiveness towards "unsafe" stimuli (Olff et al., 2013; Zik and Roberts, 2015) . Thus, when faced with positive social-emotional cues oxytocin may facilitate pro-social behaviour, trust, and cooperation. Conversely, when presented with unfamiliar or negative stimuli oxytocin administration may increase attention and alertness towards these potentially threatening, negative social-emotional cues. Although this hypothesis has not been previously linked to the effects of oxytocin on social-emotional processing, it is consistent with the present findings and is supported by several behavioural studies using investment and trust games. These studies have documented that intranasal oxytocin increases empathy towards "in-group" members as well as cooperation and compliance within the "in-group" Ten Velden et al., 2017) . Oxytocin also reduced cooperation with "outgroup" members even when the "out-group" members are generous towards the participants .
Although, the oxytocin-induced improvement in basic emotion recognition approached significance, overall the present series of meta-analyses found no significant oxytocin-induced changes in interpretation or expression of emotions among the mixed clinical population. One possible explanation is that the different disorders included in the mixed clinical group were too heterogeneous and that there were too few studies with the same disorder group to draw firm conclusions. Indeed, there was significant heterogeneity between the diagnostic groups in the present series of meta-analyses. However, there were also substantial differences in effect size estimates between studies that included patient groups with the same diagnosis, suggesting that there may be individual differences within the diagnostic groups that modulate the effects of oxytocin.
Large-scale cohort studies have documented that clinical populations have inter-individual variability with substantial heterogeneity in types of comorbidity and aetiological risk (Lamers et al., 2010; Melartin et al., 2002; Sterling et al., 2008; Wessman et al., 2009) . A few recent systematic reviews have also suggested that the effects of oxytocin on social-emotional functioning may be moderated by contextual and individual differences (Bartz et al., 2011; Olff et al., 2013) . Factors such as attachment style and experience of early parental care have been found to moderate the effects of oxytocin; those scoring low on attachment avoidance and harsh parenting showed greater oxytocininduced increase in social cooperation and positive response to crying infants (Bakermans-Kranenburg et al., 2011; Fang et al., 2014; Olff et al., 2013) . Thus, further investigation of potential contextual and individual differences that may modulate the effects of oxytocin is of interest.
Limitations, recommendations and future directions
The majority of the studies included in the present review did not meet the sample size requirement for adequate statistical power to reliably detect at least a moderate effect of the drug. Although metaanalyses are a powerful method to pool studies and increase statistical power (Greco et al., 2013) , it is important that individual studies also have adequate power. This has been suggested to be a particularly big problem in oxytocin research and the potential source of the wide range of different and sometimes contradictory findings arising from different studies (Walum et al., 2016) . These problems may go some way to explain the between-study heterogeneity and publication bias in the present review. Therefore, we recommend that future studies should recruit much larger number of participants to ensure that reliable effects of intranasal oxytocin can be detected.
Several studies investigating the effects of a single dose of intranasal oxytocin on recognition of basic emotions had evidence of ceiling effects with mean accuracy percentages over 85%. Even though presence of ceiling effects did not have significant impact on the present findings, such effects make it difficult to find the true effect of the drug or intervention because performance is already at maximum. Future studies investigating the effects of intranasal oxytocin on the recognition of basic emotions, should opt for alternative tasks, for example presenting images where the emotion is less than 100% present.
Six of the meta-analyses in the present review had evidence of between-study heterogeneity and in four of them we were unable to identify the source of the heterogeneity. Previous studies have reported several confounding factors such as individual differences in anxiety and attachment security that can influence the effects of oxytocin on social-emotional processing (Bakermans-Kranenburg et al., 2011; Fang et al., 2014; Olff et al., 2013) . The impact of these factors were not explored or reported in majority of the studies included in the present review meaning that it was not possible for us to explore the impact of these factors had on the meta-analyses. We recommend that future studies explore the impact of individual differences to gain better understanding of the impact of potential confounding factors on the effects of intranasal oxytocin.
Finally, there has recently been some doubt regarding the effects of intranasal oxytocin on social-emotional functioning in general and criticism directed at the lack of compelling theoretical framework to explain the contradictory findings reported thus far (Lane et al., 2016; Leng and Ludwig, 2016) . Some important questions have also been raised regarding if and how intranasal oxytocin accesses the brain and in what quantities (Leng and Ludwig, 2016) . These criticisms have become increasingly important to address in the light of recent replication failures (Lane et al., 2015; Radke and de Bruijn, 2015) .
We have taken some steps in the present review to introduce a potential theoretical framework, but several issues still remain unanswered. For instance, there are a number of methodological obstacles, such as individual differences in the nasal cavity physiology, the nasal spray formulations used, and the devices used to deliver the drug, that need to be considered (Quintana et al., 2016) . Furthermore, there are uncertainties regarding the site and mechanism of action of exogenous intranasal oxytocin in humans due to lack of suitable radio tracers (Paloyelis et al., 2016) . There has also been some suggestion that oxytocin has important effects in the periphery, moderating cardiovascular functioning and the peripheral cortisol response, which may influence social behaviour (Cardoso et al., 2014b; Gutkowska et al., 2014) . Further research is needed to answer these important questions particularly if oxytocin is to be used as a treatment enhancer to support clinical care.
Conclusions
The current meta-analytic review pooled studies investigating the effects of a single dose of intranasal oxytocin on social-cognition. There was no significant effect of intranasal oxytocin on interpretation or expression of emotions among the mixed clinical population. Intranasal oxytocin significantly improved recognition of basic emotions, particularly fear, and increased the expression of positive emotions, but only among the healthy individuals. These findings are in line with previous work that has found that the effects of oxytocin may be modulated by social boundaries. Further large-scale research is needed to better understand of the role of intranasal oxytocin in social-emotional processing and potential moderators of its' effects.
